A parotid tumour is an abnormal growth in the parotid gland, the largest salivary gland located just in front of and below the ear. While approximately 80% of parotid tumours are benign, all parotid lumps require specialist assessment to determine the type and whether surgical removal is needed.
The parotid gland produces saliva and sits in the cheek area, just in front of each ear. Tumours can develop within this gland as either benign (non-cancerous) or malignant (cancerous) growths. The most common benign parotid tumour is a pleomorphic adenoma, which typically presents as a slow-growing, painless lump. Warthin tumour is the second most common benign type, occurring more frequently in smokers.
Malignant parotid tumours are less common but include mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Distinguishing between benign and malignant tumours is essential because the surgical approach and need for additional treatment differ significantly.
The most common presentation is a painless lump in the cheek or jaw area, just in front of or below the ear. Many patients notice the lump incidentally or when it becomes visible. Key symptoms include:
A lump that is growing rapidly, painful, or associated with facial weakness should be assessed urgently, as these features raise concern for malignancy.
The exact cause of most parotid tumours is unknown. However, several factors may increase the risk:
At Central Sydney ENT, our head and neck surgeons use a structured approach to diagnose and characterise parotid tumours:
Clinical examination: Your surgeon will examine the lump, assess its size, mobility and consistency, and test facial nerve function. The examination also includes the neck to check for any associated lymph node enlargement.
Ultrasound: An ultrasound scan provides detailed imaging of the parotid gland and helps distinguish solid tumours from cysts. It also guides fine needle aspiration.
Fine needle aspiration biopsy (FNAB): A thin needle is used to extract cells from the tumour for laboratory analysis. This minimally invasive test helps determine whether the tumour is benign or malignant and identifies the specific tumour type in most cases.
MRI scan: MRI provides the most detailed imaging of the parotid gland, showing the tumour's size, exact location, relationship to the facial nerve, and whether it extends into deep structures. MRI is essential for surgical planning.
CT scan: May be used if there is concern about bone involvement or to assess the neck and chest for malignant tumours.
The primary treatment for most parotid tumours is surgical removal. The type of surgery depends on the tumour's location within the gland, its size, and whether it is benign or malignant.
Most benign parotid tumours are located in the superficial lobe of the gland (the portion of the gland outside the facial nerve). A superficial parotidectomy removes this portion along with the tumour while carefully preserving the facial nerve. The incision is placed in the natural skin crease in front of the ear and extends into the upper neck, healing to a well-concealed scar.
When a tumour involves both the superficial and deep lobes, or when malignancy is confirmed, a total parotidectomy may be necessary. This involves removing the entire parotid gland. The facial nerve is preserved whenever oncologically safe. In rare cases where the nerve is directly involved by cancer, nerve grafting techniques can be used to restore function.
All parotid surgery at Central Sydney ENT is performed with continuous intraoperative facial nerve monitoring. This technology provides real-time feedback to the surgeon, helping to identify and protect every branch of the facial nerve throughout the procedure. Our head and neck surgeons, including Dr Alexander Zhang, Dr Arjuna Ananda and Dr Philip Yeung, have subspecialty training in parotid and salivary gland surgery.
For confirmed malignant parotid tumours, additional treatment may include neck dissection (removal of lymph nodes) and post-operative radiotherapy. The need for adjuvant treatment is determined by the tumour type, stage, grade, and margin status, and is discussed at a multidisciplinary head and neck tumour meeting.
Most patients stay one night in hospital after parotidectomy. A small drain is usually placed to prevent fluid collection and is removed the following day. Patients can expect:
Frey syndrome (gustatory sweating, where the cheek sweats during eating) can occasionally develop months after surgery but is usually mild and manageable.
You should seek a referral to an ENT specialist if:
Parotid tumours are closely related to several other conditions managed at Central Sydney ENT:
Ask your GP for a referral to Central Sydney ENT, or call our reception team directly.
Call (02) 9747 3199